RSLS: ReShape Lifesciences, Inc. Common Stock Company Profile & Statistics

About

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.

Info & Links

CEO

Paul F. Hickey

Headquarters

18 Technology Dr, Suite 110
Irvine, CA 92618, UNITED STATES

Auditor

RSM US LLP

Share holders

Employees

ReShape Lifesciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

858.78K

Enterprise Value

15.78K

Enterprise Value/EBITDA(ttm)

-0.00

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.11

Price to Book(mrq)

0.42

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

68.34%

Operating Margin(ttm)

-86.36%

Profit Margin(ttm)

-87.16%

Return on Equity(ttm)

-179.83%

Return on Invested Capital(ttm)

-232.73%

Return on Assets(ttm)

-91.48%

Income Statement

Revenue(ttm)

8.18M

Revenue Per Share(ttm)

11.48

Gross Profit(ttm)

5.58M

EBITDA(ttm)³

-7.90M

Net Income Available to Common(ttm)

-7.07M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

1.42

52-Week Change

-87.28%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

712.68K

Dividend Yield

0.00%

Float⁴

729.00K

% Held by Insiders

0.10%

% Held by Institutions

22.06%

Balance Sheet

Total Cash(mrq)

843.00K

Total Cash Per Share(mrq)

1.18

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.33%

Quick Ratio(mrq)

0.60%

Book Value Per Share(mrq)

2.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-7.35

Free Cash Flow(ytd)

-3.74M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RSLS

ReShape Lifesciences, Inc. Common Stock

ReShape Lifesciences, Inc. Common Stock Profile